Becoming Pregnant Again

Becoming Pregnant Again
After completing hormone follow-up for hydatidiform mole, women may try for pregnancy whenever they wish. The risk of another molar pregnancy is low. More than 98% of women who become pregnant following a molar pregnancy will not have a further hydatidiform mole or be at increased risk for complications. Since patients with hydatidiform mole are at increased risk of another molar pregnancy, it is advisable for them to undergo ultrasound examinations at 10 weeks of gestation to determine if the pregnancy is progressing normally.

Most women who require treatment for malignant GTD can become pregnant again and can have normal pregnancy outcomes. After chemotherapy is completed women should postpone pregnancy for 12 months (24 months for women with stage IV disease) while they are being followed with hormone testing to make sure the tumor does not recur. There does not appear to be an increase rate of congenital malformation irrespective of the chemotherapy used. Following GTD the expectation of normal future pregnancy is about comparable to the general population.

Spotlight

Women Magazine released a special report on ovarian cancer, featuring Q&A’s with three expert SGO surgeons and important facts about the disease.

Awareness

This year’s GCAM awareness is focused on the important link between obesity and endometrial cancer. Check out the new toolkit to learn more.

Research

The Foundation for Women’s Cancer is pleased to share its 2014-2015 Research Grants and Awards booklet. The booklet describes the prizes and the application process. Prize applications are due on October 8, 2014.

Education

The next Ovarian Cancer Survivors Course will be Saturday, Sept. 20, 2014 in Columbus, Ohio. For more information on educational events and courses, click here.